CognitMarketCognitMarket

Wave Life Sciences, Inc.

Healthcare / Biotechnology

Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscular dystrophy and Huntington's disease, as well as various preclinical programs utilizing its RNA medicines platform. Wave Life Sciences, Inc. was founded in 2012 and is headquartered in Cambridge, Massachusetts.

Performance

--
Today 0.00 (0.00%)
WVE

Metrics

Market Cap905M
Latest Price$4.59
Previous Close$4.51
Volume116K
52 Week High$21.73
52 Week Low$4.40
52 Week Change-35.20%
Average Volume3.1M
Revenue65M
EPS-1.08
P/E Ratio0
Forward P/E-4.042
Price/Book1.664
Profit Margin0.00%
Operating Margin-32.48%
Return on Equity-0.67%
Dividend Yield0.00%

Recent News for WVE